Ahmad Masri

8.0k total citations · 1 hit paper
157 papers, 2.1k citations indexed

About

Ahmad Masri is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Ahmad Masri has authored 157 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Cardiology and Cardiovascular Medicine, 50 papers in Molecular Biology and 28 papers in Epidemiology. Recurrent topics in Ahmad Masri's work include Cardiomyopathy and Myosin Studies (53 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (47 papers) and Cardiovascular Function and Risk Factors (34 papers). Ahmad Masri is often cited by papers focused on Cardiomyopathy and Myosin Studies (53 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (47 papers) and Cardiovascular Function and Risk Factors (34 papers). Ahmad Masri collaborates with scholars based in United States, United Kingdom and Italy. Ahmad Masri's co-authors include Milind Y. Desai, Brian P. Griffin, Lars G. Svensson, Nicholas G. Smedira, Zoran Popović, Bruce W. Lytle, Douglas R. Johnston, Eric E. Roselli, L. Leonardo Rodriguez and Prem Soman and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Ahmad Masri

142 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy

2024 34 citations Florian Rader, Artur Oręziak et al. JACC Heart Failure profile →

Peers

Ahmad Masri

CCM

PRM

EPIDE

RNMI

Ruxandra Jurcuţ Romania

Hélène Bouvaist France

Kyle W. Klarich United States

Christophe de Meester Belgium

Christian Bruch Germany

Thomas Severin Switzerland

Roshan M. Patel United States

Oliver Bruder Germany

Muath Bishawi United States

Eric Wallace United States

Ruxandra Jurcuţ Romania

Ahmad Masri

1.4k ×1.0

CCM

207 ×0.4

512 ×1.1

PRM

296 ×0.7

EPIDE

554 ×1.9

RNMI

Citations per year, relative to Ahmad Masri Ahmad Masri (= 1×) peers Ruxandra Jurcuţ

Countries citing papers authored by Ahmad Masri

Since Specialization

Citations

This map shows the geographic impact of Ahmad Masri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Masri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Masri more than expected).

Fields of papers citing papers by Ahmad Masri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad Masri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Masri. The network helps show where Ahmad Masri may publish in the future.

Co-authorship network of co-authors of Ahmad Masri

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Masri. A scholar is included among the top collaborators of Ahmad Masri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Masri. Ahmad Masri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masri, Ahmad, Sara Saberi, Martin S. Maron, et al.. (2025). Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis. Journal of the American Heart Association. 14(17). e039551–e039551.

Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations

Sperry, Brett W., Ahmad Masri, Prem Soman, et al.. (2025). Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study. Journal of the American Heart Association. 14(23). e042530–e042530.

Masri, Ahmad, et al.. (2025). DIAGNOSTIC PERFORMANCE OF CARDIAC AND WHOLE-BODY 124I-EVUZAMITIDE (AT-01) PET/MRI IN SYSTEMIC AMYLOIDOSIS. Journal of the American College of Cardiology. 85(12). 1183–1183. 2 indexed citations

Masri, Ahmad. (2025). Cardiac magnetic resonance imaging in transthyretin amyloidosis: getting to the heart of the matter. European Heart Journal. 46(46). 5059–5061.

Blatt, Philip J., et al.. (2024). National and Regional Medicare Spending on Tafamidis, 2019-2021. JAMA Network Open. 7(9). e2426086–e2426086. 3 indexed citations

Gertz, Morie A., Julian D. Gillmore, Sami Khella, et al.. (2024). Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health‐Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis. Muscle & Nerve. 71(1). 96–107.

Butzner, Michael, et al.. (2024). The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: a literature review to inform economic model development. Journal of Medical Economics. 27(1). 817–825.

Rader, Florian, Artur Oręziak, Lubna Choudhury, et al.. (2024). Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy. JACC Heart Failure. 12(1). 164–177. 34 indexed citations breakdown →

10.

Conceição, Isabel, John L. Berk, Markus Weiler, et al.. (2024). Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform. Journal of Neurology. 271(10). 6655–6666. 4 indexed citations

11.

Altibi, Ahmed, Miriam Elman, Joaquin E. Cigarroa, et al.. (2023). Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 12(10). 21 indexed citations

12.

Brannagan, Thomas H., John L. Berk, Julian D. Gillmore, et al.. (2022). Liver‐directed drugs for transthyretin‐mediated amyloidosis. Journal of the Peripheral Nervous System. 27(4). 228–237. 19 indexed citations

13.

Abdelfattah, Omar, Matthew W. Martinez, Ahmed Sayed, et al.. (2022). Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JACC. Clinical electrophysiology. 8(11). 1417–1427. 18 indexed citations

14.

Mahtta, Dhruv, Ahmed Altibi, Mohamed M. Gad, et al.. (2021). Methodological Rigor and Temporal Trends of Cardiovascular Medicine Meta‐Analyses in Highest‐Impact Journals. Journal of the American Heart Association. 10(18). e021367–e021367. 4 indexed citations

15.

Ayoub, Karam, et al.. (2021). Implantable cardioverter‐defibrillators with end stage renal disease: Nationwide inpatient sample database results. Pacing and Clinical Electrophysiology. 45(1). 124–131. 8 indexed citations

16.

Osman, Mohammed, Moinuddin Syed, Brijesh Patel, et al.. (2021). Sex-based outcomes of surgical myectomy for hypertrophic cardiomyopathy: An analysis from the National Readmission Database. Journal of Thoracic and Cardiovascular Surgery. 166(2). 504–511.e1. 5 indexed citations

17.

Barssoum, Kirolos, Ahmed Altibi, Devesh Rai, et al.. (2020). Assessment of right ventricular function following left ventricular assist device (LVAD) implantation—The role of speckle‐tracking echocardiography: A meta‐analysis. Echocardiography. 37(12). 2048–2060. 10 indexed citations

18.

Nazer, Babak, Yan Zhao, Miriam Elman, et al.. (2020). High-intensity ultrasound catheter ablation achieves deep mid-myocardial lesions in vivo. Heart Rhythm. 18(4). 623–631. 10 indexed citations

19.

Reed, Grant W., Jeffrey Rossi, Ahmad Masri, et al.. (2019). Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease. Catheterization and Cardiovascular Interventions. 94(3). E104–E110. 6 indexed citations

20.

Masri, Ahmad, Vidyasagar Kalahasti, Lars G. Svensson, et al.. (2016). Aortic Cross-Sectional Area/Height Ratio and Outcomes in Patients With a Trileaflet Aortic Valve and a Dilated Aorta. Circulation. 134(22). 1724–1737. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact